Lannett (LCI) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free LCI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLucky Core Industries Ltd.wsj.com - September 20 at 10:13 PMLannett (LCI) Stock Sinks on Lowered Guidance, Canaccord Downgradethestreet.com - September 15 at 12:54 PMLannett Company, Inc. Enters Into Restructuring Support Agreementfinance.yahoo.com - May 1 at 7:42 AMNYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGSfinance.yahoo.com - April 20 at 7:22 AMmarketbeat.com - April 19 at 4:14 PMLANNETT SHARES UPDATEfinance.yahoo.com - April 4 at 7:46 AMWhy Lannett (LCI) Stock Is Down Todaythestreet.com - February 26 at 2:51 AMRecent uptick might appease Lannett Company, Inc. (NYSE:LCI) institutional owners after losing 26% over the past yearfinance.yahoo.com - February 7 at 8:38 AMLannett Company, Inc. (NYSE:LCI) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - February 2 at 6:07 PMLANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCEfinance.yahoo.com - February 1 at 8:39 PMLannett (LCI) Reports Q2 Loss, Tops Revenue Estimatesfinance.yahoo.com - February 1 at 8:39 PMLANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLITfinance.yahoo.com - January 25 at 6:12 PMLANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1finance.yahoo.com - January 25 at 8:11 AMLANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTSfinance.yahoo.com - January 4 at 8:32 AMLannett Company First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - November 9 at 9:24 AMLANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAMfinance.yahoo.com - November 7 at 9:31 AMLANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCEfinance.yahoo.com - November 2 at 6:35 PMLANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2finance.yahoo.com - October 26 at 8:06 AMLANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO® AT SEYMOUR PLANTfinance.yahoo.com - October 21 at 9:59 AMLANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGS - PR Newswireprnewswire.com - October 19 at 8:43 AMLANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGSfinance.yahoo.com - October 19 at 8:43 AMLCI Lannett Company, Inc.seekingalpha.com - October 15 at 12:00 AMLannett Company, Inc. (LCI)finance.yahoo.com - October 5 at 3:14 AMEx-Pharma CEO Denied 3rd Circ. Rehearing In $1M FBAR Case - Law360law360.com - September 28 at 4:09 AMProbability Of Default Is Rising For High Yield Bonds And Leveraged Loans - Forbesforbes.com - September 26 at 5:05 PMAdderall Shortages in US Spread to Two More Drug Suppliers - Bloombergbloomberg.com - September 19 at 10:47 PMWhy bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket - Amprius Technologies (NYSE:AMPX), Golden Minerals (AMEX:AUMN) - Benzingabenzinga.com - September 19 at 7:45 AM12 Health Care Stocks Moving In Friday's Intraday Session - Anixa Biosciences (NASDAQ:ANIX), Apexigen (NASDAQ:APGN) - Benzingabenzinga.com - September 16 at 5:21 PMLannett (LCI) Is Today's Water-Logged And Getting Wetter Stockthestreet.com - September 11 at 10:09 PMEx-Pharma CEO Asks 3rd Circ. To Rehear $1M FBAR Case - Law360law360.com - September 6 at 10:02 PMLANNETT ANNOUNCES SUBJECT DOSING COMPLETE FOR PIVOTAL CLINICAL TRIAL OF BIOSIMILAR INSULIN GLARGINE - Yahoo Financefinance.yahoo.com - September 2 at 5:15 AMLANNETT ANNOUNCES SUBJECT DOSING COMPLETE FOR PIVOTAL CLINICAL TRIAL OF BIOSIMILAR INSULIN GLARGINE - PR Newswireprnewswire.com - August 31 at 9:24 AMLANNETT ANNOUNCES SUBJECT DOSING COMPLETE FOR PIVOTAL CLINICAL TRIAL OF BIOSIMILAR INSULIN GLARGINEfinance.yahoo.com - August 31 at 9:24 AMNews Flash: 2 Analysts Think Lannett Company, Inc. (NYSE:LCI) Earnings Are Under Threat - Yahoo Financefinance.yahoo.com - August 27 at 7:01 PMNews Flash: 2 Analysts Think Lannett Company, Inc. (NYSE:LCI) Earnings Are Under Threatfinance.yahoo.com - August 27 at 7:01 PMElite Pharmaceuticals Inc. Receives Notification from Lannett Company, Inc. for Terminating the License, Supply and Distribution Agreement - Marketscreener.commarketscreener.com - August 27 at 8:29 AMELITE PHARMACEUTICALS INC /NV/ : Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) - Marketscreener.commarketscreener.com - August 27 at 3:29 AMLannett Company, Inc. (LCI) CEO Timothy Crew on Q4 2022 Results - Earnings Call Transcriptseekingalpha.com - August 25 at 6:04 PMLooking Into Lannett's Return On Capital Employedbenzinga.com - August 25 at 6:04 PMLannett Clocks 30% Top-Line Decline In Q4, Forecasts Lower FY23 Salesfinance.yahoo.com - August 25 at 1:04 PMEdited Transcript of LCI.N earnings conference call or presentation 24-Aug-22 8:30pm GMTfinance.yahoo.com - August 25 at 8:03 AMLannett Tops Q2 EPS by 2c By Investing.com - Investing.cominvesting.com - August 25 at 3:02 AMLannett Tops Q2 EPS by 2c By Investing.com - Investing.com UKuk.investing.com - August 24 at 5:00 PMLANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS - Yahoo Financefinance.yahoo.com - August 24 at 5:00 PMLANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTSfinance.yahoo.com - August 24 at 5:00 PMEarnings Preview: Lannett - Benzingabenzinga.com - August 23 at 5:05 PMLANNETT TO REPORT FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNES - Benzingabenzinga.com - August 19 at 7:18 AMLANNETT TO REPORT FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, AUGUST 24finance.yahoo.com - August 19 at 7:18 AMElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2023 ended June 30, 2022, and Provides Conference Call Information - Yahoo Financefinance.yahoo.com - August 15 at 11:56 PMElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2023 Financial Results on August 16, 2022 - GuruFocus.comgurufocus.com - August 11 at 4:18 PM Get Lannett News Delivered to You Automatically Sign up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details LCI Media Mentions By Week LCI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LCI News Sentiment▼0.000.43▲Average Medical News Sentiment LCI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LCI Articles This Week▼02▲LCI Articles Average Week Get Lannett News Delivered to You Automatically Sign up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cumberland Pharmaceuticals News Today Can-Fite BioPharma News Today Trevena News Today Vaccinex News Today Hepion Pharmaceuticals News Today ASLAN Pharmaceuticals News Today Pasithea Therapeutics News Today Ayala Pharmaceuticals News Today Tenax Therapeutics News Today Cadrenal Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:LCI) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lannett Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.